Concepedia

Yaling Hu

YH

20

Publications

4.9K

Citations

16

H-Index

2018

Active since

Affiliations

Sinovac Biotech(Current)

National Institutes for Food and Drug Control

Chinese Academy of Sciences

Chinese Academy of Medical Sciences & Peking Union Medical College

Institute of Biophysics

Yaling Hu is an author at Sinovac Biotech specializing in medicine, vaccination, and vaccine development.

ORCID

Top concepts

Publications per year

2018–2024

20

Publications

20

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu, Yaling Hu, Miao Xu et al. · The Lancet Infectious Diseases · 2021 · 572 citations · Full text

Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients

Xiaoli Wang, Xianghua Guo, Qianqian Xin et al. · Clinical Infectious Diseases · 2020 · 317 citations · Full text

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

Kang Wang, Zijing Jia, Linilin Bao et al. · Nature · 2022 · 194 citations · Full text

Rows per page

1–5 of 20